Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Larger and more comprehensive studies are needed to confirm whether L-carnitine has the beneficial effects observed in these small-scale studies in patients with NAFLD
A grande novidade que uma nova gerao de peptdeos vem sendo desenvolvida para ter ao mais especfica, atuando em alvos moleculares definidos e reduzindo impactos em outros sistemas do corpo
2018;7(4) ARYA Atheroscler
Insurance coverage for semaglutide can be very different from plan to plan
Huertas R, Campos Y, Diaz E, Esteban J, Vechietto L, Montanari G, D'Iddio S, Corsi M, Arenas J